KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Arbutus Biopharma (ABUS) over the last 15 years, with Dec 2024 value amounting to $2.6 million.

  • Arbutus Biopharma's Other Operating Expenses fell 22.09% to $268,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 178.79%. This contributed to the annual value of $2.6 million for FY2024, which is 3704.35% up from last year.
  • As of FY2024, Arbutus Biopharma's Other Operating Expenses stood at $2.6 million, which was up 3,704.35% from $69,000 recorded in FY2023.
  • Over the past 5 years, Arbutus Biopharma's Other Operating Expenses peaked at $2.6 million during FY2024, and registered a low of -$1.5 million during FY2020.
  • Over the past 3 years, Arbutus Biopharma's median Other Operating Expenses value was $2.2 million (recorded in 2022), while the average stood at $1.6 million.
  • In the last 5 years, Arbutus Biopharma's Other Operating Expenses slumped by 102.08% in 2020 and then soared by 3,704.35% in 2024.
  • Yearly analysis of 5 years shows Arbutus Biopharma's Other Operating Expenses stood at -$1.5 million in 2020, then skyrocketed by 224.39% to $1.9 million in 2021, then increased by 19.28% to $2.2 million in 2022, then crashed by 96.91% to $69,000 in 2023, then soared by 3,704.35% to $2.6 million in 2024.